Energenesis Biomedical (Taiwan) Market Value

6657 Stock   56.70  0.30  0.53%   
Energenesis Biomedical's market value is the price at which a share of Energenesis Biomedical trades on a public exchange. It measures the collective expectations of Energenesis Biomedical Co investors about its performance. Energenesis Biomedical is selling for under 56.70 as of the 27th of November 2024; that is 0.53% down since the beginning of the trading day. The stock's lowest day price was 56.3.
With this module, you can estimate the performance of a buy and hold strategy of Energenesis Biomedical Co and determine expected loss or profit from investing in Energenesis Biomedical over a given investment horizon. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Symbol

Energenesis Biomedical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Energenesis Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Energenesis Biomedical.
0.00
10/28/2024
No Change 0.00  0.0 
In 30 days
11/27/2024
0.00
If you would invest  0.00  in Energenesis Biomedical on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Energenesis Biomedical Co or generate 0.0% return on investment in Energenesis Biomedical over 30 days.

Energenesis Biomedical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Energenesis Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Energenesis Biomedical Co upside and downside potential and time the market with a certain degree of confidence.

Energenesis Biomedical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Energenesis Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Energenesis Biomedical's standard deviation. In reality, there are many statistical measures that can use Energenesis Biomedical historical prices to predict the future Energenesis Biomedical's volatility.

Energenesis Biomedical Backtested Returns

At this stage we consider Energenesis Stock to be very steady. Energenesis Biomedical secures Sharpe Ratio (or Efficiency) of 0.088, which denotes the company had a 0.088% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Energenesis Biomedical Co, which you can use to evaluate the volatility of the firm. Please confirm Energenesis Biomedical's Coefficient Of Variation of 876.26, downside deviation of 1.21, and Mean Deviation of 0.9974 to check if the risk estimate we provide is consistent with the expected return of 0.14%. Energenesis Biomedical has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.41, which means possible diversification benefits within a given portfolio. As returns on the market increase, Energenesis Biomedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Energenesis Biomedical is expected to be smaller as well. Energenesis Biomedical right now shows a risk of 1.54%. Please confirm Energenesis Biomedical market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to decide if Energenesis Biomedical will be following its price patterns.

Auto-correlation

    
  -0.29  

Weak reverse predictability

Energenesis Biomedical Co has weak reverse predictability. Overlapping area represents the amount of predictability between Energenesis Biomedical time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Energenesis Biomedical price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Energenesis Biomedical price fluctuation can be explain by its past prices.
Correlation Coefficient-0.29
Spearman Rank Test-0.4
Residual Average0.0
Price Variance7.79

Energenesis Biomedical lagged returns against current returns

Autocorrelation, which is Energenesis Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Energenesis Biomedical's stock expected returns. We can calculate the autocorrelation of Energenesis Biomedical returns to help us make a trade decision. For example, suppose you find that Energenesis Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Energenesis Biomedical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Energenesis Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Energenesis Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Energenesis Biomedical stock over time.
   Current vs Lagged Prices   
       Timeline  

Energenesis Biomedical Lagged Returns

When evaluating Energenesis Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Energenesis Biomedical stock have on its future price. Energenesis Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Energenesis Biomedical autocorrelation shows the relationship between Energenesis Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Energenesis Biomedical Co.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Energenesis Stock Analysis

When running Energenesis Biomedical's price analysis, check to measure Energenesis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Energenesis Biomedical is operating at the current time. Most of Energenesis Biomedical's value examination focuses on studying past and present price action to predict the probability of Energenesis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Energenesis Biomedical's price. Additionally, you may evaluate how the addition of Energenesis Biomedical to your portfolios can decrease your overall portfolio volatility.